← All companies
GWLL
Goldenwell Biotech, Inc.
$0.90
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$89.1M
Revenue (TTM)
$55.0
Net income (TTM)
-$276K
EPS (TTM)
$0.00
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$13.4K
Total assets
$18.8K
Gross margin
21.8%
52-week range
$0.20 – $10.00
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-03-31
Jul 1, 2026
10-K
Fiscal year ended 2025-12-31
Jul 1, 2026
10-Q/A
Quarter ended 2025-09-30
Jun 29, 2026
10-Q/A
Quarter ended 2025-06-30
Jun 26, 2026
10-Q/A
Quarter ended 2025-03-31
Jun 26, 2026
8-K
Previously issued financials not reliable
May 27, 2026
10-Q
Quarter ended 2025-09-30
Dec 8, 2025
10-Q
Quarter ended 2025-06-30
Sep 12, 2025
8-K
Changed accountants
Aug 19, 2025
10-Q
Quarter ended 2025-03-31
May 27, 2025
10-K
Fiscal year ended 2024-12-31
May 15, 2025
8-K
Changed accountants
Jan 23, 2025
10-Q
Quarter ended 2024-09-30
Nov 26, 2024
8-K
Changed accountants
Nov 15, 2024
10-Q
Quarter ended 2024-06-30
Aug 22, 2024
10-Q
Quarter ended 2024-03-31
May 20, 2024
8-K
Changed accountants
May 20, 2024
10-K
Fiscal year ended 2023-12-31
Apr 12, 2024
10-Q
Quarter ended 2023-09-30
Nov 13, 2023
10-Q
Quarter ended 2023-06-30
Aug 17, 2023
10-Q
Quarter ended 2023-03-31
May 19, 2023
10-K
Fiscal year ended 2022-12-31
Apr 13, 2023
10-K/A
Fiscal year ended 2021-12-31
Feb 6, 2023
10-Q
Quarter ended 2022-09-30
Nov 14, 2022
10-Q
Quarter ended 2022-06-30
Aug 15, 2022
10-Q
Quarter ended 2022-03-31
May 18, 2022
10-K
Fiscal year ended 2021-12-31
Apr 1, 2022
10-Q
Quarter ended 2021-09-30
Jan 3, 2022
10-Q
Quarter ended 2021-06-30
Dec 2, 2021
10-Q/A
Quarter ended 2020-09-30
Oct 29, 2021
8-K
Changed accountants
Sep 9, 2021
10-Q
Quarter ended 2021-03-31
Aug 5, 2021
10-K
Fiscal year ended 2020-12-31
Jul 23, 2021
10-Q
Quarter ended 2020-09-30
Feb 23, 2021
Other filings
NT 10-Q
May 12, 2026
NT 10-K
Mar 31, 2026
NT 10-Q
Aug 14, 2025
NT 10-Q
FORM NT 10-Q
May 14, 2025
NT 10-K
Apr 1, 2025
NT 10-Q
Nov 14, 2024